Cargando…
Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
AIM: The efficacy and safety of pirfenidone have been previously demonstrated in patients with mild-to-moderate idiopathic pulmonary fibrosis (IPF). However, the effect of pirfenidone in patients with advanced IPF remains unclear. Here, we investigated the effects of pirfenidone against advanced IPF...
Autores principales: | Chung, Man Pyo, Park, Moo Suk, Oh, In Jae, Lee, Heung Bum, Kim, Young Whan, Park, Jong Sun, Uh, Soo Taek, Kim, Yun Seong, Jegal, Yangjin, Song, Jin Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467484/ https://www.ncbi.nlm.nih.gov/pubmed/32297284 http://dx.doi.org/10.1007/s12325-020-01328-8 |
Ejemplares similares
-
Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study
por: Kang, Jieun, et al.
Publicado: (2023) -
Clinical Features and Outcomes of Idiopathic Pulmonary Alveolar Proteinosis in Korean Population
por: Byun, Min Kwang, et al.
Publicado: (2010) -
Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study
por: Lee, Sang Hoon, et al.
Publicado: (2018) -
Factors affecting treatment outcome in patients with idiopathic nonspecific interstitial pneumonia: a nationwide cohort study
por: Lee, Sang Hoon, et al.
Publicado: (2017) -
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
por: Lee, Sang Hoon, et al.
Publicado: (2016)